FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of ChemotherapyGeoffrey Kim, Richard Pazdur, Shenghui Tang et al.|Clinical Cancer Research|2015Cited by 532
Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptorsGaétan Ladouceur, David W. Robertson, Dale E. Mais et al.|Bioorganic & Medicinal Chemistry Letters|1991Cited by 4